| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | OP1R32D61U |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Infections | 3 | D007239 | ClinicalTrials |
| Post-Acute COVID-19 Syndrome | 3 | D000094024 | ClinicalTrials |
| Low Back Pain | 2 | D017116 | ClinicalTrials |
| Osteoarthritis, Knee | 2 | D020370 | ClinicalTrials |
| Gastroenteritis | 2 | D005759 | ClinicalTrials |
| Hypertension | 2 | D006973 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Cognition | 2 | D003071 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
| Inflammation | 2 | D007249 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 1 | D003922 | ClinicalTrials |
| Depressive Disorder | 1 | D003866 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Lewy Body Disease | 1 | D020961 | ClinicalTrials |
| Sleep Apnea, Obstructive | 1 | D020181 | ClinicalTrials |
| Anemia, Sickle Cell | 1 | D000755 | ClinicalTrials |
Related Entries
MCS
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 9004-34-6 |
| ChEMBL | CHEMBL4297557 |
| FDA SRS | OP1R32D61U |
CONTENTS